These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36603143)

  • 1. A novel mutation in collagen transport protein, MIA3 gene, detected in a patient with clinical symptoms of Ehlers-Danlos hypermobile syndrome.
    Junkiert-Czarnecka A; Pilarska-Deltow M; Bąk A; Heise M; Haus O
    Adv Clin Exp Med; 2023 Jul; 32(7):777-781. PubMed ID: 36603143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of gene encoding collagen secretion protein (SERPINH1) in the pathogenesis of a hypermobile type of Ehlers-Danlos syndrome.
    Junkiert-Czarnecka A; Pilarska-Deltow M; Bąk A; Heise M; Haus O
    Postepy Dermatol Alergol; 2023 Feb; 40(1):102-106. PubMed ID: 36909907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
    Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
    N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome.
    Forghani I
    Balkan Med J; 2019 Jan; 36(1):12-16. PubMed ID: 30063214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
    Martin A
    Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COL1A1 and COL1A2 variants in Ehlers-Danlos syndrome phenotypes and COL1-related overlap disorder.
    Venable E; Knight DRT; Thoreson EK; Baudhuin LM
    Am J Med Genet C Semin Med Genet; 2023 Jun; 193(2):147-159. PubMed ID: 36896471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermobile Ehlers-Danlos syndrome: A review and a critical appraisal of published genetic research to date.
    Scicluna K; Formosa MM; Farrugia R; Borg I
    Clin Genet; 2022 Jan; 101(1):20-31. PubMed ID: 34219226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers-Danlos syndromes.
    Igharo D; Thiel JC; Rolke R; Akkaya M; Weis J; Katona I; Schulz JB; Maier A
    Eur J Neurol; 2023 Mar; 30(3):719-728. PubMed ID: 36437696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing.
    Cortini F; Villa C; Marinelli B; Combi R; Pesatori AC; Bassotti A
    Arch Dermatol Res; 2019 May; 311(4):265-275. PubMed ID: 30826961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms.
    Ritelli M; Chiarelli N; Cinquina V; Zoppi N; Bertini V; Venturini M; Colombi M
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
    Chiarelli N; Zoppi N; Venturini M; Capitanio D; Gelfi C; Ritelli M; Colombi M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
    Thwaites PA; Gibson PR; Burgell RE
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal Symptoms in Marfan Syndrome and Hypermobile Ehlers-Danlos Syndrome.
    Inayet N; Hayat JO; Kaul A; Tome M; Child A; Poullis A
    Gastroenterol Res Pract; 2018; 2018():4854701. PubMed ID: 30151001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.
    Malfait F; Wenstrup RJ; De Paepe A
    Genet Med; 2010 Oct; 12(10):597-605. PubMed ID: 20847697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
    Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Ehlers-Danlos syndrome: the extracellular matrix scaffold in question].
    Fichard A; Chanut-Delalande H; Ruggiero F
    Med Sci (Paris); 2003 Apr; 19(4):443-52. PubMed ID: 12836217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological insights in the pathogenesis of hypermobile Ehlers-Danlos syndrome from proteome profiling of patients' dermal myofibroblasts.
    Chiarelli N; Zoppi N; Ritelli M; Venturini M; Capitanio D; Gelfi C; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166051. PubMed ID: 33383104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations.
    Ritelli M; Dordoni C; Venturini M; Chiarelli N; Quinzani S; Traversa M; Zoppi N; Vascellaro A; Wischmeijer A; Manfredini E; Garavelli L; Calzavara-Pinton P; Colombi M
    Orphanet J Rare Dis; 2013 Apr; 8():58. PubMed ID: 23587214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.